CAJ | 학술논문

缺血性卒中是一种重要的死亡和残疾原因.出血性转化(hemorrhagic transformation,HT)是急性缺血性卒中的一种严重并发症,尤其是接受静脉溶栓治疗的患者.识别HT高危患者对于改善卒中转归十分重要.一些研究表明,多种血清生物学标记物可用于预测急性缺血性卒中患者的HT风险.文章对急性缺血性卒中后HT的血清生物学标记物进行了综述.
결혈성졸중시일충중요적사망화잔질원인.출혈성전화(hemorrhagic transformation,HT)시급성결혈성졸중적일충엄중병발증,우기시접수정맥용전치료적환자.식별HT고위환자대우개선졸중전귀십분중요.일사연구표명,다충혈청생물학표기물가용우예측급성결혈성졸중환자적HT풍험.문장대급성결혈성졸중후HT적혈청생물학표기물진행료종술.
Ischemic stroke is an important cause of death and disability.Hemorrhagic transformation (HT) is a serious complication of acute ischemic stroke,especially in patients receiving intravenous thrombolytic therapy.Identifying patients at high risk of HT is very important for improving stroke outcomes.Some studied have shown that several serum biomarkers can be used to predict HT risk in patients with acute ischemic stroke.This article reviews the serum biomarkers of HT after acute ischemic stroke.